Invention Grant
- Patent Title: Packaged multi-dose liquid dextromethorphan hydrobromide formulation
-
Application No.: US15936129Application Date: 2018-03-26
-
Publication No.: US11234897B2Publication Date: 2022-02-01
- Inventor: Mark Lawrence Thuesen , Steve Shane Sanders , Steve J. Bannister
- Applicant: DXM Pharmaceutical, Inc.
- Applicant Address: US TX Katy
- Assignee: DXM Pharmaceutical, Inc.
- Current Assignee: DXM Pharmaceutical, Inc.
- Current Assignee Address: US TX Katy
- Agent Keith B. Willhelm
- Main IPC: A61K9/08
- IPC: A61K9/08 ; A61K31/485 ; A61P11/14 ; A61J1/05 ; A61J7/00 ; A61K9/00 ; A61K47/26 ; A61J1/06

Abstract:
Multi-dose packaged over-the-counter antitussive syrups comprise a bottle containing about 75 ml or less of a liquid formulation of dextromethorphan hydrobromide. The liquid formulation provides at least two doses of dextromethorphan hydrobromide. Multi-dose packaged over-the-counter liquid formulations comprise a bottle having a capacity of about 100 ml or less, at least two doses of the liquid formulation carried within the bottle, a cap, a dosage cup releasably carried on the cap and a shrink wrap substantially enveloping the bottle and the dosage cup. Antitussive syrups comprise water, dextromethorphan hydrobromide in amounts from about 6 to about 25 mg/ml, and sweetener in amounts from about 200 to about 800 mg/ml.
Public/Granted literature
- US20180271746A1 Packaged Multi-Dose Liquid Drug Formulation Public/Granted day:2018-09-27
Information query